Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer.

Authors :: Reizine N
Socco S
Weng E
Atueyi U
Mehta V
Patnaik A
Source :: JCO precision oncology [JCO Precis Oncol] 2023 Mar; Vol. 7, pp. e2200483.
Publication Year :: 2023

Subjects :: Male
Humans
Immunohistochemistry
High-Throughput Nucleotide Sequencing
Prostatic Neoplasms, Castration-Resistant drug therapy
Prostatic Neoplasms, Castration-Resistant genetics

Full Text Access

Tools